James Mullen - Thermo Fisher Independent Director
| TMO Stock | USD 543.17 4.08 0.75% |
Director
Mr. James C. Mullen is Independent Director of the Company, effective November 8, 2018. Mr. Mullen was appointed to the Boards Strategy and Finance Committee. Mr. Mullen served as Chief Executive Officer of Patheon N.V. until its acquisition by the Company in August 2017. Before joining Patheon, he served as Chief Executive Officer and President at Biogen. since 2018.
| Age | 62 |
| Tenure | 6 years |
| Address | 168 Third Avenue, Waltham, MA, United States, 02451 |
| Phone | 781 622 1000 |
| Web | https://www.thermofisher.com |
Thermo Fisher Management Efficiency
The company has Return on Asset of 0.0472 % which means that on every $100 spent on assets, it made $0.0472 of profit. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of 0.1309 %, implying that it generated $0.1309 on every 100 dollars invested. Thermo Fisher's management efficiency ratios could be used to measure how well Thermo Fisher manages its routine affairs as well as how well it operates its assets and liabilities. As of the 18th of April 2024, Return On Tangible Assets is likely to drop to 0.09. In addition to that, Return On Capital Employed is likely to drop to 0.05. At this time, Thermo Fisher's Other Assets are very stable compared to the past year. As of the 18th of April 2024, Fixed Asset Turnover is likely to grow to 4.79, while Net Tangible Assets are likely to drop (13.7 B).Similar Executives
| Showing other executives | DIRECTOR Age | ||
| Donald Ehrlich | Danaher | 80 | |
| Virginia Wilson | Charles River Laboratories | 66 | |
| Aaref Hilaly | Guardant Health | 46 | |
| Dipchand Nishar | Guardant Health | N/A | |
| Walter Lohr | Danaher | 77 | |
| Craig Thompson | Charles River Laboratories | 64 | |
| Sam Samad | IDEXX Laboratories | 48 | |
| Barry Johnson | IDEXX Laboratories | 71 | |
| Richard Wallman | Charles River Laboratories | 69 | |
| Stanley Meresman | Guardant Health | 71 | |
| Sophie Vandebroek | IDEXX Laboratories | 56 | |
| George Milne | Charles River Laboratories | 77 | |
| John Schwieters | Danaher | 81 | |
| Richard Reese | Charles River Laboratories | 75 | |
| Rebecca Henderson | IDEXX Laboratories | 57 | |
| Nancy Andrews | Charles River Laboratories | 63 | |
| Bruce Claflin | IDEXX Laboratories | 66 | |
| JeanPaul Mangeolle | Charles River Laboratories | 57 | |
| A Sanders | Danaher | 58 | |
| Ian Clark | Guardant Health | 57 | |
| M Szostak | IDEXX Laboratories | 64 | |
Management Performance
| Return On Equity | 0.13 | ||||
| Return On Asset | 0.0472 |
Thermo Fisher Scientific Leadership Team
Elected by the shareholders, the Thermo Fisher's board of directors comprises two types of representatives: Thermo Fisher inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Thermo. The board's role is to monitor Thermo Fisher's management team and ensure that shareholders' interests are well served. Thermo Fisher's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Thermo Fisher's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Thomas Loewald, Sr. VP and President of Analytical Instruments | ||
| Jim Manzi, Independent Chairman of the Board | ||
| Michel Lagarde, Senior Vice President and President, Pharma Services | ||
| Mark Stevenson, Executive VP and President of Life Sciences Solutions | ||
| Rafael Tejada, Vice Relations | ||
| Stephen Williamson, Chief Financial Officer, Senior Vice President | ||
| Kenneth Apicerno, Vice President Investor Relations | ||
| Tyler Jacks, Independent Director | ||
| James Mullen, Independent Director | ||
| Dion Weisler, Independent Director | ||
| Karen Nelson, Chief Officer | ||
| Debora Spar, Independent Director | ||
| Peter Hornstra, Vice President Chief Accounting Officer | ||
| Andrew Thomson, Senior Vice President and Presidentident - Specialty Diagnostics | ||
| Martiny Harris, Independent Director | ||
| Judy Lewent, Independent Director | ||
| Michael Boxer, Senior Vice President General Counsel | ||
| Ruby Chandy, Director | ||
| Joseph Holmes, Chief Accounting Officer, Vice President | ||
| Lars Sorensen, Independent Director | ||
| Peter Wilver, Chief Admin. Officer and Executive VP | ||
| C Harris, Independent Director | ||
| Elaine Ullian, Independent Director | ||
| Thomas Lynch, Director, Chairman of Nominating and Corporate Governance Committee and Member of Compensation Committee | ||
| Alan Malus, Executive VP and President of Laboratory Products and Services | ||
| Daniel Shine, Senior Vice President and Presidentident, Analytical Instruments | ||
| William Parrett, Independent Director | ||
| Ryan Snyder, Senior Officer | ||
| Nelson Chai, Independent Director | ||
| Sperling Sperling, Independent Director | ||
| Patrick Durbin, Senior Vice President and Presidentident - Specialty Diagnostics | ||
| Syed Jafry, Senior Vice President and President Regions | ||
| Martin Harris, Independent Director | ||
| Marc Casper, CEO and President Director, Member of Strategy and Fin. Committee and Member of Science and Technology Committee | ||
| Michael Esq, Senior Counsel | ||
| Gregory Herrema, Senior Vice President | ||
| Sandy Pound, VP Officer | ||
| Scott Sperling, Independent Director | ||
| Seth Hoogasian, Senior Vice President General Counsel, Secretary | ||
| R Keith, Independent Director | ||
| Gianluca Pettiti, Senior Vice President and Presidentident - Specialty Diagnostics business |
Thermo Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Thermo Fisher a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.13 | ||||
| Return On Asset | 0.0472 | ||||
| Profit Margin | 0.14 % | ||||
| Operating Margin | 0.19 % | ||||
| Current Valuation | 240.2 B | ||||
| Shares Outstanding | 381.71 M | ||||
| Shares Owned By Insiders | 0.17 % | ||||
| Shares Owned By Institutions | 92.22 % | ||||
| Number Of Shares Shorted | 2.58 M | ||||
| Price To Earning | 30.99 X |
Thermo Fisher Investors Sentiment
The influence of Thermo Fisher's investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in Thermo. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock market does not have solid backing from leading economists and market statisticians.
Investor biases related to Thermo Fisher's public news can be used to forecast risks associated with an investment in Thermo. The trend in average sentiment can be used to explain how an investor holding Thermo can time the market purely based on public headlines and social activities around Thermo Fisher Scientific. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Thermo Fisher's market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Thermo Fisher's and other traded tickers. The bigger the bubble, the more accurate is the estimated score. Higher bars for a given day show more participation in the average Thermo Fisher's news discussions. The higher the estimated score, the more favorable is the investor's outlook on Thermo Fisher.
Thermo Fisher Implied Volatility | 65.13 |
Thermo Fisher's implied volatility exposes the market's sentiment of Thermo Fisher Scientific stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Thermo Fisher's implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Thermo Fisher stock will not fluctuate a lot when Thermo Fisher's options are near their expiration.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Thermo Fisher in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Thermo Fisher's short interest history, or implied volatility extrapolated from Thermo Fisher options trading.
Currently Active Assets on Macroaxis
When determining whether Thermo Fisher Scientific offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Thermo Fisher's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Thermo Fisher Scientific Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Thermo Fisher Scientific Stock:Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Thermo Fisher Scientific. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in population. You can also try the Equity Search module to search for actively traded equities including funds and ETFs from over 30 global markets.
Complementary Tools for Thermo Stock analysis
When running Thermo Fisher's price analysis, check to measure Thermo Fisher's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Thermo Fisher is operating at the current time. Most of Thermo Fisher's value examination focuses on studying past and present price action to predict the probability of Thermo Fisher's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Thermo Fisher's price. Additionally, you may evaluate how the addition of Thermo Fisher to your portfolios can decrease your overall portfolio volatility.
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope |
Is Thermo Fisher's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Thermo Fisher. If investors know Thermo will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Thermo Fisher listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.054 | Dividend Share 1.4 | Earnings Share 15.47 | Revenue Per Share 111.028 | Quarterly Revenue Growth (0.05) |
The market value of Thermo Fisher Scientific is measured differently than its book value, which is the value of Thermo that is recorded on the company's balance sheet. Investors also form their own opinion of Thermo Fisher's value that differs from its market value or its book value, called intrinsic value, which is Thermo Fisher's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Thermo Fisher's market value can be influenced by many factors that don't directly affect Thermo Fisher's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Thermo Fisher's value and its price as these two are different measures arrived at by different means. Investors typically determine if Thermo Fisher is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Thermo Fisher's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.